# UK Medical Oxygen Concentrators Market > UK Medical Oxygen Concentrators Market Research Report: Size, Share, Trend Analysis By Product Type (Portable Oxygen Concentrators, Stationary Oxygen Concentrators), By Technology (Continuous Flow, Pulse Dose), By Indication (Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Others) and By End Users (Hospitals and Clinics, Homecare Settings, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.13% - **2024:** $ 224.38 Million - **2025:** $ 242.62 Million - **2035:** $ 530 Million - **Key Players:** Philips (NL), Invacare (US), AirSep (US), GCE Group (NO), OxyGo (US), Drive DeVilbiss Healthcare (GB), Nidek Medical (JP), Caire Inc. (US) **Report ID:** MRFR/MED/49058-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-medical-oxygen-concentrators-market-50815 --- ## Market Summary ## **UK Medical Oxygen Concentrators Market Overview** As per MRFR analysis, the UK Medical Oxygen Concentrators Market Size was estimated at 126.75 (USD Million) in 2023. The UK Medical Oxygen Concentrators Market Industry is expected to grow from 134.62(USD Million) in 2024 to 507.18 (USD Million) by 2035. The UK Medical Oxygen Concentrators Market CAGR (growth rate) is expected to be around 12.815% during the forecast period (2025 - 2035). **Key UK Medical Oxygen Concentrators Market Trends Highlighted** The UK Medical Oxygen Concentrators Market is currently witnessing several key market drivers that are shaping its landscape. The aging population in the UK, which is projected to grow significantly, has led to an increase in respiratory diseases such as COPD and asthma. This demographic shift is contributing to a higher demand for oxygen therapy solutions, including concentrators, as patients seek more effective management of their conditions. Additionally, the trend towards home healthcare is gaining momentum, driven by the desire for user-friendly devices that allow patients to receive care in the comfort of their homes while also reducing the burden on healthcare facilities. Opportunities abound in the UK market, particularly as technological advancements continue to enhance the functionality and portability of medical oxygen concentrators. The introduction of lightweight, compact, and battery-operated models is opening doors for market players to cater to a broader segment of patients, including those who are more mobile. The UK government’s focus on improving air quality and public health further strengthens the prospects for enhanced oxygen therapy solutions as initiatives aimed at combating pollution and respiratory illnesses gain traction. Trends in recent times indicate a growing acceptance of telemedicine and remote monitoring in conjunction with oxygen therapy.Patients are increasingly being monitored remotely, enhancing compliance and providing healthcare professionals with vital data for better treatment decisions. Moreover, the emergence of new distribution channels, such as online sales platforms, is making oxygen concentrators more accessible to end-users across the UK. As this market continues to evolve, it aligns with the broader goals of the National Health Service in promoting patient-centric care and ensuring that all individuals have access to necessary medical resources. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **UK Medical Oxygen Concentrators Market Drivers** **Increasing Prevalence of Respiratory Diseases** The growing incidence of chronic respiratory conditions, including asthma and Chronic Obstructive Pulmonary Disease (COPD), is a major factor propelling the UK medical oxygen concentrators market. Over 1.2 million individuals in the UK already have COPD, according to current figures. As the population ages and smoking-related illnesses rise, this number is predicted to rise. The National Health Service (NHS) reports that respiratory conditions make up a significant percentage of hospital admissions; COPD alone causes over 115,000 admissions each year. Because patients need home oxygen therapy to manage their conditions, this increase raises the demand for medical oxygen concentrators. This creates numerous opportunities for suppliers and manufacturers in the UK Medical Oxygen Concentrators Market Industry to broaden their product offerings and meet the demands of healthcare providers. Additionally, groups like the British Lung Foundation and Asthma UK are aggressively raising patient awareness and management techniques, which is driving market expansion by raising demand for oxygen therapy products. **the Technological Advancements in Medical Devices** The advancement of technology in medical devices is a significant driver for the UK Medical Oxygen Concentrators Market Industry. Recent developments have led to the emergence of portable and more efficient oxygen concentrators that provide enhanced user-friendly features. For instance, innovations such as continuous flow technology and advanced filtration systems are not only improving the efficacy of oxygen delivery but are also making these devices more accessible to patients and healthcare providers. The NHS has endorsed such technological strides by highlighting the importance of efficient oxygen therapy in improving patient outcomes. In the past decade, the introduction of lightweight and battery-operated oxygen concentrators has allowed greater mobility for users, significantly enhancing their quality of life. This shift toward modernized equipment is fueling market growth and positioning established manufacturers such as Philips and Invacare to capture a larger share of the UK Medical Oxygen Concentrators Market. **Rising Elderly Population and Associated Health Needs** The UK's elderly population is rapidly growing, which is expected to boost the UK Medical Oxygen Concentrators Market Industry significantly. Data from the Office for National Statistics (ONS) reveals that by 2030, individuals aged 65 and over are predicted to account for over 23% of the UK population. This demographic shift correlates strongly with the increased prevalence of age-related respiratory diseases, creating an urgent requirement for home healthcare solutions, including medical oxygen concentrators. As the elderly population increases, the demand for medical oxygen solutions, especially for those with chronic respiratory issues, is projected to rise. The rising trend towards aging in place, reinforced by government initiatives, is further encouraging patients to pursue at-home therapeutic options, thereby creating a supportive environment for market growth within the UK Medical Oxygen Concentrators Market Industry. Organizations such as Age UK emphasize the importance of supporting the elderly, which in turn fuels demand for oxygen therapy devices. **UK Medical Oxygen Concentrators Market Segment Insights** **Medical Oxygen Concentrators Market Product Type Insights** The UK Medical Oxygen Concentrators Market exhibits a diverse range of product types, primarily classified into Portable Oxygen Concentrators and Stationary Oxygen Concentrators. Portable Oxygen Concentrators are increasingly popular among patients requiring mobility without sacrificing oxygen supply, representing a major demand driven by lifestyle preferences and the increasing need for home healthcare solutions. These concentrators facilitate active patient lifestyles, making them crucial for individuals with chronic respiratory conditions who need regular oxygen therapy.Conversely, Stationary Oxygen Concentrators typically cater to patients who spend much of their time at home, offering a continuous supply of oxygen for more comprehensive care. This type is preferred for its higher output capabilities and often longer lifespan, addressing the needs of individuals with more severe health conditions. In the growing landscape of the UK Medical Oxygen Concentrators Market, both product types play a significant role in meeting patient needs, influencing market growth by providing essential support for varying levels of oxygen therapy requirements. While Portable Oxygen Concentrators dominate in terms of flexibility and convenience, Stationary Oxygen Concentrators hold substantial value in providing robust oxygen therapy for patients with chronic illnesses. The segmentation of the market highlights how manufacturers are innovating to enhance product features, driven by consumer trends towards portability and convenience, as well as the rise in chronic respiratory diseases. The rising aging population in the UK, coupled with increasing awareness and advancements in healthcare technology, further propels the demand for innovative solutions in both categories, ensuring continued market growth. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Medical Oxygen Concentrators Market Technology Insights** The Technology segment of the UK Medical Oxygen Concentrators Market comprises various innovative solutions that cater to the growing demand for portable and efficient oxygen delivery systems. Continuous Flow and Pulse Dose are two prominent types within this segment. Continuous Flow technology provides a steady stream of oxygen, making it ideal for patients who require a constant supply, such as those with chronic respiratory conditions. This method is widely adopted due to its reliability and ease of use. On the other hand, Pulse Dose technology is gaining traction as it offers a more efficient oxygen delivery option, activating only during inhalation, thereby optimizing oxygen usage and enhancing patient comfort.The rising prevalence of respiratory ailments and an increasing elderly population in the UK are key factors driving the demand for these technologies. Additionally, advancements in technology are fostering the development of lighter, more compact devices that are easier for patients to manage. These factors contribute significantly to the overall growth of the UK Medical Oxygen Concentrators Market and underscore the importance of each technology in improving patient care and outcomes. **Medical Oxygen Concentrators Market Indication Insights** The UK Medical Oxygen Concentrators Market, categorized under the Indication segment, displays a significant presence driven largely by the increasing prevalence of Chronic Obstructive Pulmonary Disease (COPD), asthma, and sleep apnea among the aging population. COPD represents a major health concern in the UK, accounting for a substantial portion of respiratory diseases, leading to a growing demand for home healthcare solutions, including oxygen concentrators. The rising diagnosis of asthma, influenced by environmental factors and allergies, further propels the requirement for supplemental oxygen interventions.Additionally, sleep apnea's rising awareness and diagnosis contribute to the market's expansion, as effective management of this condition often necessitates oxygen therapy. Other factors, such as increased hospital admissions due to respiratory distress and innovations in oxygen delivery technologies, are also enhancing the market dynamics. These indications collectively underscore the critical role that oxygen concentrators play in patient management while also presenting opportunities for market growth within the UK medical industry. As healthcare providers focus on offering patient-centered care, the demand for reliable, efficient, and portable medical oxygen solutions continues to climb, illustrating robust forecasting of the UK Medical Oxygen Concentrators Market data in the coming years. **Medical Oxygen Concentrators Market End User Insights** The End User segment of the UK Medical Oxygen Concentrators Market plays a crucial role in the market's landscape. It can be categorized into three main areas: Hospitals and Clinics, Homecare Settings, and Others. Hospitals and Clinics remain a dominant segment due to the high demand for medical oxygen in emergency care and respiratory treatments, with healthcare facilities increasingly investing in advanced technologies to enhance patient care. Homecare Settings are also gaining traction, propelled by the rise in chronic respiratory diseases and an aging population that favors at-home treatment options, offering convenience and flexibility for patients and caregivers alike. The 'Others' category encompasses various niche markets, such as rehabilitation centers and long-term care facilities, which are becoming significant as they adopt medical oxygen solutions to cater to specialized patient needs. With the increasing focus on improving healthcare outcomes and the push towards patient-centered care in the UK, this segmentation is expected to evolve and expand, highlighting the importance of access to oxygen therapy across different healthcare environments. Overall, the End User segment reflects critical trends and growth opportunities within the UK Medical Oxygen Concentrators Market as it adapts to the changing dynamics in healthcare provision. **UK Medical Oxygen Concentrators Market Key Players and Competitive Insights** The UK Medical Oxygen Concentrators Market is characterized by a dynamic competitive landscape shaped by technological advancements, a growing patient population with respiratory conditions, and increasing awareness about home healthcare solutions. The market comprises a mix of established players and emerging companies, each striving to capture market share through innovative products and enhanced service offerings. Several factors influence competition, including product quality, pricing strategies, distribution channels, and the ability to forge partnerships with healthcare providers. The ongoing demand for oxygen therapy devices, driven by the rising prevalence of chronic obstructive pulmonary disease and other respiratory illnesses, presents a lucrative opportunity for businesses in this field. Companies in the market are focusing on research and development to launch advanced and more efficient oxygen concentrators while also navigating regulatory requirements to ensure product compliance and safety.Chart Industries has established a strong presence in the UK Medical Oxygen Concentrators Market with its high-quality product offerings and innovative technologies. The company benefits from its extensive experience in the field of gas separation and liquefaction. Chart Industries is known for its state-of-the-art oxygen concentrators that combine reliability with user-friendly features, catering to both healthcare facilities and home users. The company's commitment to sustainability and efficient energy consumption aligns well with increasing environmental concerns in the UK, enhancing its appeal among eco-conscious consumers. Furthermore, Chart Industries has developed strategic partnerships within the healthcare ecosystem, allowing the company to leverage synergies and expand its market reach effectively. The firm’s robust distribution network and customer support services further strengthen its competitive position in the marketplace.Mediwatch also plays a significant role in the UK Medical Oxygen Concentrators Market with its wide range of products designed for respiratory care. The company is well-regarded for its focus on product innovation, having developed several technologically advanced oxygen concentrators tailored to meet the needs of patients in diverse environments. Mediwatch emphasizes quality and reliability, positioning itself as a trusted brand among healthcare providers and patients alike. Additionally, the company has engaged in strategic mergers and acquisitions to enhance its product portfolio and distribution capabilities, thereby increasing its market presence in the UK. Mediwatch’s offerings include portable and stationary oxygen concentrators, which cater to the growing demand for flexible oxygen therapy solutions. The company's strengths lie in its strong focus on customer service, product training, and after-sales support, which help in building long-term relationships with customers and improving patient outcomes. **Key Companies in the UK Medical Oxygen Concentrators Market Include** - Chart Industries - Mediwatch - Zechin Medical - OxyGo - Nidek Medical Products - Caire Inc - Tillomed Laboratories - Philips - Ozark Medical - Linde Healthcare - Invacare - Drive DeVilbiss Healthcare - GCE Healthcare - Inogen - AirSep **UK Medical Oxygen Concentrators Market Industry Developments** The UK Medical Oxygen Concentrators Market has experienced significant developments recently, particularly in response to the ongoing health challenges faced by the population. Key players such as Chart Industries, Mediwatch, and Philips have reported a noticeable increase in demand for oxygen concentrators due to respiratory conditions exacerbated by the COVID-19 pandemic. In September 2023, Invacare and Drive DeVilbiss Healthcare announced enhancements in their product offerings, focusing on more efficient and portable oxygen concentrators. The market valuation for oxygen concentrators has been boosted by increased healthcare spending and growing awareness of home healthcare solutions. In June 2023, Linde Healthcare completed the acquisition of OxyGo, integrating its advanced technology to improve oxygen delivery systems. Other notable happenings include ongoing collaborations among GCE Healthcare and Caire Inc. to develop innovative solutions for homecare settings. The focus on patient-centered care has driven investments in Research and Development among these companies. Furthermore, the restrictive regulatory environment continues to be a critical factor, influencing the lifecycle and launch of new oxygen concentrator models across the UK, catering to the rising demand for reliable and efficient respiratory aids. **UK Medical Oxygen Concentrators Market Segmentation Insights** **Medical Oxygen Concentrators Market Product Type****Outlook** - Portable Oxygen Concentrators - Stationary Oxygen Concentrators **Medical Oxygen Concentrators Market Technology****Outlook** - Continuous Flow - Pulse Dose **Medical Oxygen Concentrators Market Indication****Outlook** - Chronic Obstructive Pulmonary Disease - Asthma - Sleep Apnea - Others **Medical Oxygen Concentrators Market End User****Outlook** - Hospitals and Clinics - Homecare Settings - Others ## Market Drivers ### Growing Geriatric Population The medical oxygen-concentrators market is significantly influenced by the growing geriatric population in the UK. As individuals age, they often experience a decline in respiratory function, leading to an increased need for supplemental oxygen. The Office for National Statistics indicates that the proportion of individuals aged 65 and over is projected to rise to 23% by 2035. This demographic shift is likely to result in a higher prevalence of age-related respiratory conditions, thereby driving demand for medical oxygen concentrators. Additionally, older adults are more likely to prefer home-based healthcare solutions, which further supports the market. Healthcare providers are increasingly focusing on tailored oxygen therapy solutions for this population, indicating a strong potential for growth in the medical oxygen-concentrators market. ### Supportive Regulatory Framework A supportive regulatory framework is crucial for the growth of the medical oxygen-concentrators market. In the UK, regulatory bodies are actively working to streamline the approval processes for medical devices, including oxygen concentrators. This regulatory support not only ensures the safety and efficacy of products but also encourages innovation within the industry. The Medicines and Healthcare products Regulatory Agency (MHRA) has established guidelines that facilitate the introduction of new technologies while maintaining high standards of patient care. As a result, manufacturers are more inclined to invest in the development of advanced oxygen concentrators, knowing that they can navigate the regulatory landscape effectively. This environment fosters competition and drives market growth, as companies strive to meet the evolving needs of healthcare providers and patients alike. ### Rising Awareness of Home Healthcare Solutions The medical oxygen-concentrators market is benefiting from an increasing awareness of home healthcare solutions among patients and caregivers in the UK. As healthcare systems evolve, there is a noticeable shift towards providing care in home settings, which is often more comfortable and cost-effective. Patients are becoming more informed about the benefits of using oxygen concentrators at home, leading to a surge in demand. According to market analysis, the home healthcare segment is expected to grow at a CAGR of over 8% in the coming years. This trend is further supported by the availability of various reimbursement policies that cover home oxygen therapy, making it more accessible to patients. Consequently, the medical oxygen-concentrators market is likely to expand as more individuals opt for home-based oxygen therapy solutions. ### Increasing Prevalence of Respiratory Disorders The medical oxygen-concentrators market is experiencing growth due to the rising incidence of respiratory disorders in the UK. Conditions such as chronic obstructive pulmonary disease (COPD) and asthma are becoming more prevalent, leading to an increased demand for oxygen therapy. According to recent health statistics, approximately 1.2 million people in the UK are diagnosed with COPD, which necessitates the use of oxygen concentrators for effective management. This trend indicates a growing patient population that requires continuous oxygen supply, thereby driving the market forward. Furthermore, the aging population, which is more susceptible to respiratory ailments, is likely to contribute to the sustained demand for medical oxygen concentrators. As healthcare providers seek to improve patient outcomes, the focus on oxygen therapy is expected to intensify, further propelling the medical oxygen-concentrators market. ### Technological Innovations in Oxygen Concentrators Technological advancements play a pivotal role in shaping the medical oxygen-concentrators market. Innovations such as portable and lightweight designs, enhanced efficiency, and user-friendly interfaces are attracting both healthcare providers and patients. The introduction of smart oxygen concentrators, which can monitor oxygen levels and provide real-time data, is particularly noteworthy. These devices not only improve patient compliance but also facilitate remote monitoring by healthcare professionals. The market is projected to grow as manufacturers invest in research and development to create more efficient and effective products. For instance, the integration of battery-operated systems allows for greater mobility, catering to the needs of patients who require oxygen therapy while maintaining an active lifestyle. Such advancements are likely to enhance the overall appeal of medical oxygen concentrators, thereby stimulating market growth. ## Future Outlook The [Medical Oxygen Concentrators Market](https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876) is projected to grow at an 8.13% CAGR from 2025 to 2035, driven by increasing respiratory diseases, aging population, and technological advancements. **New opportunities:** - Development of portable oxygen concentrators for home use - Integration of telehealth services with oxygen therapy - Expansion of rental services for oxygen concentrators in healthcare facilities By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Product Type: Portable Oxygen Concentrators (Largest) vs. Stationary Oxygen Concentrators (Fastest-Growing) The market share distribution within the product type segment of the UK medical oxygen-concentrators market shows a clear dominance of portable oxygen concentrators, which account for a significant portion of overall usage. Their flexibility and ease of transport cater to the increasing demand for mobile healthcare solutions, especially among elderly patients. Stationary oxygen concentrators, while traditionally favored in healthcare facilities, are now gaining traction as they benefit from advancements in technology and increased awareness about their applications in home healthcare settings. The growth trends in this segment are heavily driven by changing patient needs and preferences towards portable solutions. Factors such as an aging population, rising incidences of respiratory diseases, and advancements in product technology contribute to the surge in demand. The portable segment is likely to continue dominating due to its convenience, while stationary oxygen concentrators are emerging rapidly, fueled by innovations that enhance their efficiency and usability in both home and hospital environments. Portable Oxygen Concentrators (Dominant) vs. Stationary Oxygen Concentrators (Emerging) Portable oxygen concentrators are leading the market due to their compact, lightweight design, allowing users to maintain mobility while receiving therapy. These devices are especially popular among active patients and those requiring supplemental oxygen during travel. In comparison, stationary oxygen concentrators are emerging as reliable solutions for patients who prefer long-term use at home. They typically provide higher oxygen output and are more cost-effective for continuous use. The advancements in both segment types, including improved energy efficiency and user-friendly features, contribute to their growing acceptance among healthcare providers and patients alike, defining their roles in the evolving landscape of respiratory care. ### By Technology: Continuous Flow (Largest) vs. Pulse Dose (Fastest-Growing) The UK medical oxygen-concentrators market showcases a diverse technology spectrum with Continuous Flow units leading in market share. This segment holds a sizable portion due to their reliability and consistent oxygen delivery, making them a preferred choice for long-term patients. Conversely, Pulse Dose technology is emerging as a strong competitor, capitalizing on its efficiency and portable design, which appeals to active users who require on-the-go solutions. Growth in this sector is driven by an increasing prevalence of respiratory conditions and an aging population, necessitating innovative solutions. Continuous Flow remains favored for its established presence, but Pulse Dose is gaining traction, with advancements in technology enhancing user experience. This competitive landscape is poised for further evolution as consumer preferences and medical needs change. Technology: Continuous Flow (Dominant) vs. Pulse Dose (Emerging) The Continuous Flow segment has established itself as a dominant player in the UK medical oxygen-concentrators market, characterized by its ability to provide a steady stream of oxygen. This makes it particularly suitable for patients with chronic respiratory issues who require constant therapy. In contrast, the Pulse Dose technology represents an emerging trend, catering to those who need less oxygen at intervals, thereby enhancing portable use and battery efficiency. Pulse Dose units are increasingly favored by active individuals, allowing for greater mobility and quality of life. With advancements in both areas, Continuous Flow maintains its lead, but Pulse Dose is rapidly gaining ground, driven by technological innovations and shifting user needs. ### By Indication: COPD (Largest) vs. Sleep Apnea (Fastest-Growing) In the UK medical oxygen-concentrators market, Chronic Obstructive Pulmonary Disease (COPD) holds the largest share, driven by the rising prevalence of respiratory disorders among the aging population. Asthma and other conditions also contribute significantly to the market, but their share is comparatively smaller. Sleep Apnea is emerging as a noteworthy segment, with increasing awareness and diagnosis, contributing to changing market dynamics. The growth of the COPD segment is primarily supported by the high demand for long-term oxygen therapy due to lifestyle factors such as smoking and pollution. In contrast, the Sleep Apnea segment is experiencing rapid growth due to technological advancements, such as improved portable oxygen solutions and increased patient awareness about the condition, leading to higher adoption rates. This shift indicates a diversification in treatment approaches within the market. COPD: Dominant vs. Sleep Apnea: Emerging Chronic Obstructive Pulmonary Disease (COPD) remains the dominant indication for medical oxygen concentrators, attributed to its chronic nature and the necessity for ongoing respiratory support. Patients suffering from COPD often require long-term oxygen therapy, thereby creating a sustained demand for these devices. The market for COPD-related treatments is well-established, with a significant number of patients reliant on daily oxygen therapy for managing their condition. On the other hand, Sleep Apnea is an emerging indication, experiencing rapid growth in market interest as awareness increases. This segment is characterized by innovative product offerings tailored for home use and a burgeoning emphasis on lifestyle adjustments to manage sleep disorders, leading to a growing customer base. ### By End User: Hospitals and Clinics (Largest) vs. Homecare Settings (Fastest-Growing) In the UK medical oxygen-concentrators market, hospitals and clinics represent the largest segment, driven by the high demand for oxygen therapy and patient care in acute settings. This segment has a significant market share as these healthcare facilities require reliable and effective solutions to manage patients with respiratory conditions. In contrast, homecare settings are rapidly gaining traction, catering to the growing number of patients requiring oxygen therapy at home, thus highlighting a shift towards more personalized and accessible care options. The growth trends in this sector are predominantly influenced by the rising prevalence of chronic respiratory diseases and the increasing geriatric population in the UK. Moreover, advancements in technology and product innovations are making oxygen concentrators more efficient and user-friendly, bolstering their adoption in homecare settings. With the continuous push towards home healthcare solutions, the homecare segment is expected to experience exponential growth, representing a critical component of the overall market dynamics. Hospitals and Clinics (Dominant) vs. Homecare Settings (Emerging) The hospitals and clinics segment is characterized by its dominant position in the UK medical oxygen-concentrators market, where oxygen delivery systems are essential for immediate care. This segment not only influences product development but also drives innovations that enhance patient outcomes. In contrast, homecare settings are emerging as a vital segment, catering to patients who prefer receiving oxygen therapy in the comfort of their own homes. This shift is facilitated by improved technologies that make oxygen concentrators more efficient, portable, and user-friendly. As healthcare systems undergo transformation towards outpatient services, the homecare segment is positioned for robust growth, responding to the rising demand for personalized healthcare solutions. ## Competitive Benchmarking The medical oxygen-concentrators market is currently characterized by a dynamic competitive landscape, driven by increasing demand for home healthcare solutions and advancements in technology. Key players such as Philips (NL), Invacare (US), and Drive DeVilbiss Healthcare (GB) are strategically positioned to leverage innovation and regional expansion to enhance their market presence. Philips (NL) focuses on integrating digital health solutions into its product offerings, while Invacare (US) emphasizes partnerships with healthcare providers to improve patient access to oxygen therapy. Drive DeVilbiss Healthcare (GB) is enhancing its operational focus on supply chain optimization to ensure timely delivery of products, collectively shaping a competitive environment that prioritizes quality and accessibility. The market structure appears moderately fragmented, with several players competing for market share. Key business tactics include localizing manufacturing to reduce costs and improve responsiveness to market demands. This strategy not only enhances supply chain efficiency but also allows companies to adapt to regional regulatory requirements. The collective influence of these key players fosters a competitive atmosphere where innovation and customer-centric approaches are paramount. In October 2025, Philips (NL) announced the launch of a new line of portable oxygen concentrators designed for enhanced mobility and user-friendliness. This strategic move is significant as it aligns with the growing trend of patients seeking more flexible healthcare solutions, thereby potentially increasing Philips' market share in the home healthcare segment. The introduction of these devices may also reinforce the company's commitment to integrating advanced technology into its product offerings, further differentiating it from competitors. In September 2025, Invacare (US) entered into a strategic partnership with a leading telehealth provider to enhance remote patient monitoring capabilities for oxygen therapy users. This collaboration is likely to improve patient outcomes by facilitating real-time data sharing between patients and healthcare professionals, thus positioning Invacare as a forward-thinking leader in the integration of technology and healthcare services. Such initiatives may also enhance patient adherence to therapy, which is crucial for long-term success in this market. In August 2025, Drive DeVilbiss Healthcare (GB) expanded its manufacturing capabilities by investing in a new facility in the UK, aimed at increasing production capacity for oxygen concentrators. This investment is indicative of the company's strategy to meet rising demand while ensuring compliance with local regulations. By enhancing its manufacturing footprint, Drive DeVilbiss is likely to improve its supply chain reliability and responsiveness, which are critical factors in maintaining competitive advantage. As of November 2025, current trends in the medical oxygen-concentrators market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on technological advancements, product reliability, and sustainable practices. This shift underscores the importance of innovation and supply chain efficiency as key drivers of success in the market. ## Recent News & Developments The UK Medical Oxygen Concentrators Market has experienced significant developments recently, particularly in response to the ongoing health challenges faced by the population. Key players such as Chart Industries, Mediwatch, and Philips have reported a noticeable increase in demand for oxygen concentrators due to respiratory conditions exacerbated by the COVID-19 pandemic. In September 2023, Invacare and Drive DeVilbiss Healthcare announced enhancements in their product offerings, focusing on more efficient and portable oxygen concentrators. The market valuation for oxygen concentrators has been boosted by increased healthcare spending and growing awareness of home healthcare solutions. In June 2023, Linde Healthcare completed the acquisition of OxyGo, integrating its advanced technology to improve oxygen delivery systems. Other notable happenings include ongoing collaborations among GCE Healthcare and Caire Inc. to develop innovative solutions for homecare settings. The focus on patient-centered care has driven investments in Research and Development among these companies. Furthermore, the restrictive regulatory environment continues to be a critical factor, influencing the lifecycle and launch of new oxygen concentrator models across the UK, catering to the rising demand for reliable and efficient respiratory aids. ## Report Scope | MARKET SIZE 2024 | 224.38(USD Million) | | --- | --- | | MARKET SIZE 2025 | 242.62(USD Million) | | MARKET SIZE 2035 | 530.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.13% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Philips (NL), Invacare (US), AirSep (US), GCE Group (NO), OxyGo (US), Drive DeVilbiss Healthcare (GB), Nidek Medical (JP), Caire Inc. (US) | | Segments Covered | Product Type, Technology, Indication, End User | | Key Market Opportunities | Integration of advanced telehealth solutions enhances accessibility in the medical oxygen-concentrators market. | | Key Market Dynamics | Rising demand for home healthcare drives innovation and competition in the medical oxygen-concentrators market. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What is the current valuation of the UK medical oxygen-concentrators market?** A: The market valuation was $224.38 Million in 2024. **Q: What is the projected market size for the UK medical oxygen-concentrators market by 2035?** A: The market is projected to reach $530.0 Million by 2035. **Q: What is the expected CAGR for the UK medical oxygen-concentrators market during the forecast period 2025 - 2035?** A: The expected CAGR is 8.13% during the forecast period. **Q: Which product types dominate the UK medical oxygen-concentrators market?** A: The market includes portable oxygen concentrators valued at $80.0 - $190.0 Million and stationary oxygen concentrators valued at $144.38 - $340.0 Million. **Q: What technologies are utilized in the UK medical oxygen-concentrators market?** A: The market features Continuous Flow and Pulse Dose technologies, each valued at $112.19 - $265.0 Million. **Q: What are the primary indications for medical oxygen concentrators in the UK?** A: Key indications include Chronic Obstructive Pulmonary Disease (COPD) valued at $80.0 - $190.0 Million, Asthma at $50.0 - $120.0 Million, and Sleep Apnea at $40.0 - $90.0 Million. **Q: Who are the key players in the UK medical oxygen-concentrators market?** A: Key players include Philips, Invacare, AirSep, GCE Group, OxyGo, Drive DeVilbiss Healthcare, Nidek Medical, and Caire Inc. **Q: What are the main end-user segments for medical oxygen concentrators in the UK?** A: End-user segments include Hospitals and Clinics valued at $80.0 - $190.0 Million and Homecare Settings valued at $120.0 - $290.0 Million. **Q: How does the market for medical oxygen concentrators in the UK compare to other regions?** A: While specific regional comparisons are not provided, the UK market is characterized by robust growth and significant investments from leading companies. **Q: What trends are influencing the growth of the UK medical oxygen-concentrators market?** A: Trends include increasing demand for homecare settings and advancements in technology, which may drive market expansion. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-medical-oxygen-concentrators-market-50815*